IL-6 (proinflammatory) and IL-10 (anti-inflammatory) are two cytokines commonly dysregulated in COVID-19 patients and the ratio of IL6-to-IL10 may be used to predict outcomes of COVID-19 patients [37–39]. Here, IL10 is linked to COVID-19.